Fluvoxamine is a selective serotonin reuptake inhibitor (SSRI) that works by blocking the recycling of serotonin in the brain, leaving more of this chemical messenger available in the spaces between nerve cells. It is FDA-approved for treating obsessive-compulsive disorder (OCD) in adults and children aged 8 and older, and it has a few distinctive properties that set it apart from other SSRIs.
How It Increases Serotonin
After a nerve cell releases serotonin to send a signal, it normally pulls that serotonin back in through a protein called the serotonin transporter. Fluvoxamine binds to this transporter and blocks the reuptake process. The result is that serotonin stays in the gap between neurons longer, amplifying its signaling effects. This is the same basic mechanism shared by all SSRIs, including sertraline, fluoxetine, and escitalopram.
The boost in serotonin signaling doesn’t produce immediate symptom relief. The brain needs time to adjust to the new chemical environment, which is why most people don’t notice meaningful improvement for several weeks. During that adjustment period, the brain’s serotonin receptors gradually become less sensitive, and downstream changes in mood and anxiety circuits begin to take hold.
What Makes Fluvoxamine Different From Other SSRIs
Fluvoxamine stands out from the SSRI class because of its strong activity at sigma-1 receptors. These receptors are found throughout the brain, particularly in areas affected by stress and depression. When fluvoxamine activates sigma-1 receptors, it may promote the growth of new nerve cells and trigger adaptive changes in brain wiring that help protect against the effects of chronic stress. Other SSRIs have much weaker activity at this receptor, which gives fluvoxamine a pharmacological profile that goes beyond simple serotonin reuptake inhibition.
Another distinguishing feature is what fluvoxamine does not do. Some antidepressants block histamine, acetylcholine, or adrenaline-related receptors as a side effect of their main action, which can cause drowsiness, dry mouth, or foggy thinking. Fluvoxamine has relatively low activity at these receptors compared to certain other antidepressants, which may translate to fewer problems with cognitive side effects for some people.
What It Treats
The FDA has approved fluvoxamine specifically for OCD. In a controlled trial comparing extended-release fluvoxamine to placebo, people taking the medication saw their OCD symptom scores drop by about 32%, compared to a 21% drop in the placebo group. That gap may sound modest on paper, but for someone trapped in hours of daily compulsions, it can represent a meaningful shift in functioning.
Fluvoxamine is also widely prescribed off-label for conditions like social anxiety disorder, depression, post-traumatic stress disorder, and panic disorder. It gained attention during the COVID-19 pandemic for possible anti-inflammatory properties linked to its sigma-1 receptor activity, though its role in treating infections remains outside its standard use.
How the Dose Is Adjusted Over Time
Fluvoxamine is typically taken once daily at bedtime. For adults with OCD, the starting dose is 50 mg, then gradually increased by 50 mg every four to seven days based on how well it’s tolerated and whether symptoms are improving. Most adults end up on a dose somewhere between 100 and 300 mg per day, with 300 mg being the ceiling.
Children aged 8 to 11 start lower, at 25 mg, and can be increased in 25 mg steps up to a maximum of 200 mg daily. Adolescents aged 12 to 17 follow the same gentle titration but can go up to the adult maximum of 300 mg. An extended-release version is also available for adults, starting at 100 mg and adjusted in 50 mg increments at weekly intervals. The slow, stepwise approach gives the body time to adapt and helps minimize side effects during the early weeks.
Drug Interactions Worth Knowing About
Fluvoxamine is one of the most potent inhibitors of a liver enzyme called CYP1A2. This enzyme is responsible for breaking down caffeine, among many other substances. In clinical testing, people taking fluvoxamine had caffeine metabolites drop below detectable levels, meaning the drug essentially shuts down caffeine processing in the body. If you drink coffee while on fluvoxamine, you may feel much stronger and longer-lasting effects from the same cup you used to tolerate easily.
It also moderately inhibits another liver enzyme, CYP2C19, which plays a role in metabolizing several other medications. The practical consequence is that fluvoxamine can raise blood levels of drugs processed by these pathways, sometimes to a clinically significant degree. This makes it especially important to review all medications, supplements, and even caffeine intake with a prescriber before starting treatment.
Common Side Effects
Like other SSRIs, fluvoxamine’s most frequent side effects stem from increased serotonin activity throughout the body, not just in the brain. Nausea is the most commonly reported issue, particularly during the first week or two, and it tends to improve as the body adjusts. Drowsiness is also common, which is partly why the medication is dosed at bedtime. Other typical effects include headache, dizziness, and changes in appetite or sexual function.
Taking fluvoxamine at bedtime and starting at a low dose both help reduce the intensity of early side effects. Most people find that nausea and drowsiness fade within the first few weeks, while the therapeutic benefits are just beginning to emerge. The mismatch in timing between side effects (which come early) and symptom relief (which comes later) is one of the most frustrating aspects of starting any SSRI, and knowing this ahead of time can help you stick with the treatment long enough for it to work.